Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 186 results for "Cgix"

Cancer Genetics inks $5M capital raise via direct placement; s...

Cancer Genetics (NASDAQ: CGIX ) slumps11%premarket on modest volume in response to its announcement of a $5M direct equity offering to institutional investors who will also receive one warrant to purchase 1/2 of a share of common stock at $2.25 for ... Seeking Alpha, 2 months ago

15 images for Cgix

SleekMoney, 2 months ago
American Banking News - Forex, 2 months ago
American Banking News - Forex, 3 months ago
American Banking News, 3 months ago
SleekMoney, 3 months ago
American Banking News, 3 months ago
American Banking News - Forex, 4 months ago
SleekMoney, 4 months ago
Nasdaq, 4 months ago
Nasdaq, 4 months ago

Cancer Genetics, Inc. Receives New York State Approval for Focus::CLL, a Unique NGS Panel for Chronic Lymphocytic Leukemia, Reinforcing the Company's Market-Leading Position in the Diagnosis and Management of B-Cell Cancers

GlobeNewswire 2016-06-30 RUTHERFORD, N.J., June 30, 2016 (GLOBE NEWSWIRE) -- Cancer Genetics, Inc. (Nasdaq:CGIX) (CGI or The Company), a leader in enabling precision medicine for oncology through molecular markers and diagnostics, announced today ...
 BizWire Express4 weeks ago Cancer Genetics, Inc. Expands Its Immuno-Oncology Franchise With The Addition of The FDA-Approved Ventana PD-L1 (sp142) Assay As A Complementary Diagnostic Test For TECENTRIQ?  Pharmacy Choice4 weeks ago Cancer Genetics, Inc. to Present at the 2016 LD Micro Invitational Investor Conference  BizWire Express1 month ago Cancer Genetics Announces $5 Million Registered Direct Offering  BioSpace2 months ago
[x]  

Sabby Management LLC Increases Stake in Cancer Genetics Inc. (CGIX)

Sabby Management LLC increased its position in Cancer Genetics Inc. (NASDAQ:CGIX) by 28.5% during the first quarter, Holdings Channel reports. The institutional investor owned 81,300 shares of the company's stock after buying an additional 18,049 ...
 Ticker Report2 weeks ago Renaissance Technologies LLC Has $204,000 Stake in Cancer Genetics Inc. (CGIX)  WKRB News3 weeks ago Sabby Healthcare Master Fund, Ltd Owns Stake in Cancer Genetics Inc (CGIX)  WKRB News2 months ago
SleekMoney

Cancer Genetics Inc. (CGIX) Sees Large Volume Increase

Cancer Genetics Inc. (NASDAQ:CGIX) shares saw unusually-high trading volume on Thursday . Approximately 140,961 shares traded hands during trading, a decline of 1% from the previous session's volume of 141,911 shares.The stock last traded at $2.04 ...
 Ticker Report3 weeks ago Cancer Genetics Inc (CGIX) Short Interest Update  Mideast Time1 month ago Cancer Genetics Inc (CGIX) Shares Up 2.9%  Ticker Report1 month ago Cancer Genetics Inc (CGIX) Trading Down 1.8%  Ticker Report1 month ago
[x]  

Health Care Sector Update for 06/30/2016: CGIX

Copyright (C) 2014 MTNewswires.com. All rights reserved. Unauthorized reproduction is
 Nasdaq4 weeks ago

CANCER GENETICS (CGIX)

. CANCER GENETICS (NASDAQ:CGIX) Smart Scan Chart Analysis confirms that a short term counter trend move is underway. When this action is over look for the longer term negative trend to resume. Downtrend with money management stops. The ...
 INO.com1 month ago

HTG Molecular Diagnostics and Cancer Genetics Announce Presentation of an Immuno-Oncology Study at the American Society of Clinical Oncology (ASCO) 2016 Annual Meeting

HTG Molecular Diagnostics, Inc. (Nasdaq:HTGM) (HTG), a provider of instruments and reagents for molecular profiling applications, and Cancer Genetics, Inc. (Nasdaq:CGIX) (CGI), a leader in enabling precision medicine for oncology through molecular ...
 BioSpace1 month ago
[x]  

CANCER GENETICS : Partners with ArcherDX to Offer ArcherĀ® NGS Assays as a Sequencing Service for Biotech and Pharma

Boulder, CO - ArcherDX, Inc., a leader in NGS-based gene fusion detection, has announced that Cancer Genetics, Inc., (CGI) has become a Certified Service Provider of Archer FusionPlex NGS assays. Additionally, CGI plans to use Archer VariantPlexTM ...
 4 Traders1 month ago Cancer Genetics, Inc. Partners with ArcherDX to Offer ArcherĀ® NGS Assays as a Sequencing Service for Biotech and Pharma  Equities.com1 month ago
[x]  

Mayo's Relationship With Anti-Cancer Biotech Firm Revealed

The first commercialization fruits of a joint venture between the Mayo Clinic's individualized medicine program and a New Jersey-based anti-cancer biotech firm are about to be realized, and with it, more financial details about their privately-held ...
 Twin Cities Business2 months ago

Cancer Genetics, Inc. Launches The Most Comprehensive & Clinically Actionable Next Generation Sequencing Panel in Precision Medicine, FOCUS::Lymphoma

FOCUS::Lymphoma panel is being used to power several clinical trials with biotech and pharmaceutical companies, and is now available for use in a clinical setting FOCUS::Lymphomacan be personalized to report on clinically actionable gene mutations ...
 Benzinga.com2 months ago CANCER GENETICS : Launches The Most Comprehensive & Clinically Actionable Next Generation Sequencing Panel in Precision Medicine,...  4 Traders2 months ago Cancer Genetics Launches The Most Comprehensive & Clinically Actionable Next Generation Sequencing Panel In Precision Medicine, FOCUS::Lymphoma  BioSpace2 months ago
[x]  
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less